Format

Send to

Choose Destination
Res Pract Thromb Haemost. 2020 Feb 14;4(2):334-342. doi: 10.1002/rth2.12310. eCollection 2020 Feb.

Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.

Author information

1
Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital London UK.
2
Department of Haematology University College London London UK.
3
Department of Biochemistry University of Cambridge Cambridge UK.
4
Population Health Sciences Bristol University Bristol UK.
5
Department of Pathology Faculty of Medicine and Surgery University of Malta Msida Malta.
6
School of Biosciences & Medicine University of Surrey Guildford UK.

Abstract

Background:

Impaired thrombin generation (TG) in patients with acquired coagulopathy, is due to low coagulation factors and thrombocytopenia. The latter is typically treated with platelet transfusions and the former with plasma and occasionally with prothrombin complex concentrates (PCCs). We hypothesized that manipulating the concentrations of coagulation factors might result in restoration of platelet-dependent TG over and above that of simple replacement therapy.

Objective:

To investigate the influence of PCCs on impaired TG secondary to thrombocytopenia.

Methods:

TG was evaluated by thrombin generation assay using a thrombocytopenia model in which normal plasma samples with varying platelet counts (20-300 × 109/L) were spiked with PCCs (25%-150% increase in plasma PCC levels).

Results:

PCCs and platelets significantly increased TG in a dose-dependent manner in vitro. Two-way repeated measures of analysis of variance showed variance in peak height, area under the curve, time to peak, and velocity. This variance explained, respectively, by levels of PCC was 47, 59, 25 and 53%; by platelet count was 45, 28, 44, and 14%; by the combination was 80, 67, 70, and 62% variance; and a combination with additional interaction was 91, 84, 76, and 68%. TG at a platelet count 40 × 109/L with an approximate 25% increase in PCC concentration was similar to TG at 150 × 109/L. Similarly, patient samples spiked ex vivo with PCCs also showed highly significant improvements in TG.

Conclusions:

Impaired TG of thrombocytopenia is improved by PCCs, supporting the need for additional studies in complex coagulopathies characterized by mild to moderate thrombocytopenia and abnormal coagulation.

KEYWORDS:

acquired coagulopathy; blood coagulation disorders; blood platelets; prothrombin complex concentrates; thrombin; thrombocytopenia

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center